Parkinson's Disease Trial, Recruiting NCT03551392 Sponsor: University of Florida Condition: Parkinson's Disease
Back to Parkinsons Disease

Parkinson's Disease Trial, Recruiting

NCT03551392
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have no signs of dementia or mild memory impairment, based on standard memory and thinking tests
  • You are able to give your own consent to participate and can complete memory and mood tests on a computer
  • You have at least an 8th grade education or can read at that level
  • You are willing to be randomly assigned to either the real treatment or a "sham" (inactive) version of the treatment
  • You are able to commit 12 weeks to the treatment, plus extra time for testing before and after
  • You have been on the same doses of your main medications for at least two months and plan to keep taking them during the study (including any memory-related medications your doctor may have prescribed)
  • You are able to carry out your normal day-to-day activities without significant difficulty

Who may not be able to join:

  • You have had a major stroke, significant brain condition, or surgery on the brain (such as multiple sclerosis, seizures, or moderate traumatic brain injury) — note that Parkinson's disease may be an exception (confirm with trial site)
  • You have an unstable or poorly controlled serious medical condition, such as certain metabolic disorders, HIV, or moderate to severe kidney or liver disease
  • You have a current or recent history (within the past 6 months) of serious mental health conditions such as schizophrenia, active psychosis, bipolar disorder, a current major depressive episode, or alcohol or substance misuse
  • You are currently taking antipsychotic medications, strong sedatives, or other medications that block a brain chemical called acetylcholine, as these could affect memory
  • You have used certain light-sensitive medications (such as steroids or retin-A) within 15 days of starting the study
  • You have been diagnosed with active cancer
  • You have significant difficulties with movement or vision that would prevent you from using a computer or seeing colors
  • You have taken part in a brain training study in the last 3 months, or are currently involved in another study involving brain training or a similar treatment
  • You are unable to have a brain scan (MRI) due to claustrophobia or having certain metal implants in your body, such as a pacemaker, heart valve, brain aneurysm clips, braces, non-removable body jewelry, or metal fragments

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Dawn Bowers, Ph.D., University of Florida

Phone: 352-273-5270

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
26 June 2019
Est. completion
30 April 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

ARENA, learning and memory change from baseline to post-testing

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov